Foregene Co., Ltd. has announced its latest breakthrough in the field of genotyping, which enables researchers to complete the genotyping of a mouse tissue sample, from tissue digestion to PCR readout, in just an hour and a half. This cutting-edge technology is made possible by Foregene's proprietary Direct PCR platform, which is capable of rapid genotyping of mouse tissue using a tissue PCR kit.
The Direct PCR platform is a revolutionary new way of genotyping mouse tissue that eliminates the need for time-consuming DNA extraction steps. Instead, the technology allows for direct genotyping of tissue samples, which provides researchers with the ability to quickly analyze large samples of genetic material with minimal effort. Foregene's breakthrough technology is therefore a significant advance over current genotyping methods, which require days or weeks of laboratory work to obtain results.
Foregene's Direct PCR platform is a result of Foregene's expertise in the production and development of molecular biology lab reagents and IVD kits. The company is focused on providing the scientific community with cutting-edge tools, reagents, and kits that are essential for diverse research applications, including genotyping.
Foregene's extensive experience in molecular biology lab reagent development, production, and marketing has led the company to explore new avenues of research and product development that cater to various research needs. The company's double-column RNA isolation platform, and DNA-only silica membrane platform have become popular among researchers worldwide.
The Direct PCR platform is the latest addition to Foregene's suite of proprietary technologies that enable researchers to simplify their research workflows and generate rapid results. Similar to other Foregene products, the Direct PCR platform is user-friendly, and the kit's protocol is straightforward.
Furthermore, Foregene has developed a tissue PCR kit, which is specifically tailored to work seamlessly with the Direct PCR platform. The kit's Extract-N-Amp Tissue PCR Kit is designed to maximize the amplification effectiveness of genomic DNA from a range of tissues, including tail tips, ear punches, and other relevant mouse tissues. The kit's streamlined protocol involves tissue digestion, and PCR readout can be performed in one step.
The streamlined workflow that the Direct PCR platform offers allows for real-time analysis, thereby eliminating the need for post-PCR gel electrophoresis. Foregene's technology enables researchers to perform fast and accurate PCR analysis and provides the advantage of reducing the workload, and therefore the time and labor required for such research.
In conclusion, Foregene Co., Ltd.'s latest tissue PCR kit's Direct PCR platform is a significant milestone for the genotyping of mouse tissue. The popular Extract-N-Amp system for mouse tail has improved, making it more accessible to laboratories worldwide. The kit's one-step, easy-to-use protocol offers benefits in speeding up research workflows while reducing labor hours and costs. The company's proprietary Direct PCR platform, combined with the Extract-N-Amp Tissue PCR Kit expertise, brings Foregene's longstanding commitment to advancing the life sciences research industry to the next level. Foregene's Direct PCR platform offers several advantages that will undoubtedly change the future of genotyping, to the delight of researchers worldwide.